Dr. Ivan Litvinov's research at McGill University focuses on understanding the genetic underpinnings of cutaneous T-cell lymphoma (CTCL) and its progression. They are actively developing a molecular test to diagnose and prognose CTCL, differentiating it from benign conditions and identifying high-risk patients. Dr. Litvinov's work also explores the role of cancer testis and embryonic stem cell genes in CTCL and investigates innovative treatments using oncolytic viruses. Additionally, the laboratory examines the geographic distribution of cancers in Canada, shedding light on regional cancer patterns.